Clinical characterization might help in preventing osteonecrosis of the jaw
- PMID: 19088052
- DOI: 10.1158/1078-0432.CCR-08-1428
Clinical characterization might help in preventing osteonecrosis of the jaw
Comment on
-
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.Clin Cancer Res. 2008 Apr 15;14(8):2387-95. doi: 10.1158/1078-0432.CCR-07-1430. Clin Cancer Res. 2008. PMID: 18413829
Similar articles
-
Drug induced osteonecrosis of the jaws.J Tenn Dent Assoc. 2006 Spring;86(2):18-9. J Tenn Dent Assoc. 2006. PMID: 16895006 No abstract available.
-
Treating osteonecrosis.Br Dent J. 2006 Mar 11;200(5):242-3. doi: 10.1038/sj.bdj.4813366. Br Dent J. 2006. PMID: 16528300 No abstract available.
-
Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.Gen Dent. 2005 Nov-Dec;53(6):392-5. Gen Dent. 2005. PMID: 16366043 Review. No abstract available.
-
Bisphosphonates.J Am Dent Assoc. 2006 May;137(5):584; discussion 584. doi: 10.14219/jada.archive.2006.0238. J Am Dent Assoc. 2006. PMID: 16739534 No abstract available.
-
Osteonecrosis of the jaws and bisphosphonates.Alpha Omegan. 2007;100(4):194-202. doi: 10.1016/j.aodf.2007.10.013. Alpha Omegan. 2007. PMID: 18335818 Review. No abstract available.
Cited by
-
New evidence on bisphosphonate related osteonecrosis of the jaws suggests dental referral prior to commencement of treatment.Hippokratia. 2009 Jan;13(1):64. Hippokratia. 2009. PMID: 19240827 Free PMC article. No abstract available.
-
Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding 'risks and benefits of bisphosphonates'.Br J Cancer. 2009 Feb 24;100(4):670. doi: 10.1038/sj.bjc.6604550. Epub 2008 Aug 5. Br J Cancer. 2009. PMID: 18682707 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical